Litcius/Paper detail

Cerebral Venous Sinus Thrombosis After BNT162b2 mRNA COVID-19 Vaccination

Yoshitaka Yamaguchi, Luna Kimihira, Hikaru Nagasawa, Kyoichi Seo, Manabu Wada

2021Cureus14 citationsDOIOpen Access PDF

Abstract

W present a rare case of cerebral venous sinus thrombosis after the BNT162b2 mRNA COVID-19 vaccine. A 61-year-old Japanese man developed a headache 10 days after the first dose of the vaccine. Magnetic resonance venography and contrast-enhanced brain MRI showed thrombosis in the superior sagittal sinus and the right transverse sinus. Anticoagulation with intravenous unfractionated heparin followed by oral warfarin was started. His headache improved, and brain MRI on day 22 showed resolution of thrombus. He was maintained on anticoagulation with warfarin and discharged without any neurological sequelae. This case is presented in the context of the relevant literature.

Topics & Concepts

MedicineCerebral venous sinus thrombosisWarfarinSuperior sagittal sinusContext (archaeology)ThrombusThrombosisVenous thrombosisHeparinMagnetic resonance imagingCoronavirus disease 2019 (COVID-19)RadiologySurgeryInternal medicineAtrial fibrillationInfectious disease (medical specialty)PaleontologyBiologyDiseaseHeparin-Induced Thrombocytopenia and ThrombosisCerebral Venous Sinus ThrombosisVenous Thromboembolism Diagnosis and Management